Tadawul Saudi Stock Screener

Screen Tadawul (Saudi Arabia) stocks by market cap, valuation and fundamentals. Built for analysts, quant researchers, fintech builders and AI agents. Factual public data — not financial or investment advice.

📊 What you get

Clean JSON, one record per stock. Key fields (full output has 25 fields per stock):

• symbol — Exchange ticker symbol
• name — Company name
• price_sar — Latest traded price (local currency)
• market_cap_display — Market cap, human-readable (e.g. €12.4B)
• market_cap_sar — Market capitalization
• pct_change — Daily percent change
• revenue_ttm_billion_sar — Trailing-twelve-month revenue
• is_native_saudi — Index-membership flag
• currency — Reporting currency
• scraped_at — Data timestamp
• stockanalysis_url — Source / reference URL

All prices in SAR.

Local-market specifics: SAR is USD-pegged at 3.75; USD conversions (market_cap_billion_usd) are included and is_tasi flags TASI members.

Pricing: $0.25 per stock (Pay-Per-Event) — about 4 stocks per $1. A $0.01 actor-start fee applies per run.

🤖 Use with AI agents

This actor returns structured JSON built for LLM and agent pipelines — no data-vendor contract, no scraping to maintain. Point Claude, a custom OpenAI Agents SDK tool, an n8n flow, or any MCP-aware client at it and get TASI fundamentals on demand. Ask for a filtered slice and the agent gets exactly the rows it needs.

Sample agent prompt:

Screen the TASI for dividend yield > 4% and market cap > $1B, return the top 20 as JSON.

Agentic payments (x402): Supports agentic payment via x402 — agents can call this actor with USDC, no API key required.

⏰ Run on a schedule

Refresh your screen weekly with a scheduled run:

{
  "limit": 50
}

🔗 Related screeners

Other EMEA exchanges: Germany (Xetra), UK (LSE), South Africa (JSE), Turkey (BIST)

All 25+ markets in one place: Global Equities Screener MCP — the agent front door to every NexGenData screener.

---

Data sourced from public market pages and filings. Factual public data — not financial or investment advice.